Attached files
file | filename |
---|---|
10-K - CAPRICOR THERAPEUTICS, INC. | v176034_10k.htm |
EX-31.1 - CAPRICOR THERAPEUTICS, INC. | v176034_ex31-1.htm |
EX-31.2 - CAPRICOR THERAPEUTICS, INC. | v176034_ex31-2.htm |
EX-23.2 - CAPRICOR THERAPEUTICS, INC. | v176034_ex23-2.htm |
EX-23.1 - CAPRICOR THERAPEUTICS, INC. | v176034_ex23-1.htm |
EX-32.2 - CAPRICOR THERAPEUTICS, INC. | v176034_ex32-2.htm |
EX-10.14 - CAPRICOR THERAPEUTICS, INC. | v176034_ex10-14.htm |
EXHIBIT
32.1
CERTIFICATION
OF CHIEF EXECUTIVE OFFICER
CERTIFICATION
PURSUANT TO
18 U.S.C.
SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant
to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, the undersigned officer of Nile Therapeutics, Inc.
(the “Company”) hereby
certifies, to such officer’s knowledge, that:
(1) the
Annual Report on Form 10-K of the Company for the year ended December 31, 2009
(the “Report”) fully
complies with the requirements of Section 13(a) or Section 15(d), as
applicable, of the Securities Exchange Act of 1934, as amended; and
(2) the
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
Date
March 3, 2010
/s/ Joshua
Kazam
|
Joshua
Kazam
|
Title:
Chief Executive Officer
|